BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37824130)

  • 1. Oncologic Outcome in Advanced Oral Squamous Cell Carcinoma After Refusal of Recommended Adjuvant Therapy.
    Mrosk F; Doll C; Scheer J; Neumann F; Hofmann E; Kreutzer K; Voss J; Rubarth K; Beck M; Heiland M; Koerdt S
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):1027-1033. PubMed ID: 37824130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.
    Farrokhian N; Holcomb AJ; Dimon E; Karadaghy O; Ward C; Whiteford E; Tolan C; Hanly EK; Buchakjian MR; Harding B; Dooley L; Shinn J; Wood CB; Rohde S; Khaja S; Parikh A; Bulbul MG; Penn J; Goodwin S; Bur AM
    JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):947-955. PubMed ID: 36074415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
    Spoerl S; Gerken M; Mamilos A; Fischer R; Wolf S; Nieberle F; Klingelhöffer C; Meier JK; Spoerl S; Ettl T; Reichert TE; Spanier G
    Clin Oral Investig; 2021 Apr; 25(4):1705-1713. PubMed ID: 32754787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Margin Assessment Methods in Oral Cavity Squamous Cell Carcinoma and Recurrence: Tumor Bed vs Resection Specimen Sampling.
    Wu SS; Woody N; Hesse J; Cook S; Cracolici V; Ku JA; Prendes B; Silver N; Scharpf J; Brauer PR; Reddy CA; Campbell SR; Koyfman SA; Burkey B; Lamarre ED
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):1011-1020. PubMed ID: 37768650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of Occult Invasive Disease in Patients With Biopsy-Proven Oral Cavity Squamous Cell Carcinoma in Situ.
    Cooper DJ; Ziemba Y; Pereira L; Kann BH; Parashar B; Miles BA; Ghaly M; Seetharamu N; Frank D; Talcott WJ
    JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):151-156. PubMed ID: 38175664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Fluorescence Visualization-Guided Surgery on Local Recurrence of Oral Squamous Cell Carcinoma: A Randomized Clinical Trial.
    Durham JS; Brasher P; Anderson DW; Yoo J; Hart R; Dort JC; Seikaly H; Kerr P; Rosin MP; Poh CF
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1149-1155. PubMed ID: 33034628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
    Chow JCH; Cheuk W; Cho WCS; Wong CF; Au DWY; Tam AHP; Wong RCW; Chan JCH; Law SCC; Ngan RKC; Wong KH; Cheung KM
    JAMA Netw Open; 2023 Jul; 6(7):e2323890. PubMed ID: 37459093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: A retrospective cohort study from 2000 to 2019.
    Justesen MM; Stampe H; Jakobsen KK; Andersen AO; Jensen JM; Nielsen KJ; Gothelf AB; Wessel I; Christensen A; Grønhøj C; von Buchwald C
    Oral Oncol; 2024 Feb; 149():106684. PubMed ID: 38211527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological safety of submental island flap for reconstruction of pathologically node-negative and node-positive T1-2 oral squamous cell carcinoma-related defects: A retrospective study and comparison of outcomes.
    Wang J; Tan Y; Shen Y; Lv M; Li J; Sun J
    Oral Oncol; 2020 Mar; 102():104507. PubMed ID: 31896500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic and vascular invasion in oral squamous cell carcinoma: Implications for recurrence and survival in a population-based cohort study.
    Spoerl S; Gerken M; Fischer R; Mamilos A; Spoerl S; Wolf S; Pohl F; Klingelhöffer C; Ettl T; Reichert TE; Spanier G
    Oral Oncol; 2020 Dec; 111():105009. PubMed ID: 33032181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment.
    Id Said B; Ailles L; Karamboulas C; Meens J; Huang SH; Xu W; Keshavarzi S; Bratman SV; Cho BCJ; Giuliani M; Hahn E; Kim J; O'Sullivan B; Ringash J; Waldron J; Spreafico A; de Almeida JR; Chepeha DB; Irish JC; Goldstein DP; Hope A; Hosni A
    JAMA Otolaryngol Head Neck Surg; 2022 Apr; 148(4):342-349. PubMed ID: 35238880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Involvement of Lymph Node Density in Oral Squamous Cell Carcinoma. A New Predictive Model.
    Verde-Sánchez L; Capote AL; Sanz-García A; Brabyn P; Rodríguez-Campo FJ; Naval Gías L
    J Oral Maxillofac Surg; 2023 Mar; 81(3):358-369. PubMed ID: 36502856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Performance of a New Staging Category to Improve Discrimination of Disease-Specific Survival in Nonmetastatic Oral Cancer.
    Lee CC; Huang CY; Lin YS; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; Chen HC; Yang CC
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):395-402. PubMed ID: 28125757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.
    Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):180-7. PubMed ID: 21232996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative Radiotherapy and Survival in Oral Cavity Squamous Cell Carcinoma With Mandibulectomy.
    Harley RJ; Iheagwara UK; Faraji F; Sridharan S; Kubik MW
    JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):233-239. PubMed ID: 38300601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Factors Are Associated With Regional Recurrence After Operative Treatment of Oral Squamous Cell Carcinoma?
    Troeltzsch M; Haidari S; Boser S; Troeltzsch M; Probst FA; Ehrenfeld M; Otto S
    J Oral Maxillofac Surg; 2018 Dec; 76(12):2650-2659. PubMed ID: 30098956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prognosis of neck dissection with sternocleidomastoid muscle preservation and resection in advanced oral squamous cell carcinoma: a retrospective cohort analysis].
    Chen XJ; Fan RY; Tao SC; Xue R; Wen XT; Mai HM
    Shanghai Kou Qiang Yi Xue; 2023 Dec; 32(6):609-614. PubMed ID: 38494969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node biopsy in lieu of neck dissection for staging oral cancer.
    Rigual N; Loree T; Frustino J; Jayaprakash V; Cohan D; Sullivan M; Kuriakose MA
    JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):779-82. PubMed ID: 23868306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.